Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

ローカル自動翻訳 · 情報源の原言語

概要

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

情報源の原言語: Federal Register — Justice Department原文の発表を開く →

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Title-Age, Sex, Race, and Ethnicity (ASRE) of Persons Arrested Under 18 Years of Age; ASRE of Persons Arrested Under 18 Years of Age and Over

Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection, for Which Approval Has Expired: Title-2026 National Survey of Victim Service Providers

規制物質輸入者 アプリケーション:フィッシャー・クリニック・サービス,インク.

規制物質輸入者アプリケーション:フィッシャー・クリニック・サービス,インク.